Global Sleep Disorder Therapies Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 91

Report ID: 9108

Sleep disorders involve problems with the quality, timing and amount of sleep, which cause problems with functioning and distress during the daytime.
In 2018, the global Sleep Disorder Therapies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Sleep Disorder Therapies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sleep Disorder Therapies development in United States, Europe and China.

The key players covered in this study
Sanofi
Phillips Healthcare
Nox Medical
Fisher and Paykel Healthcare
Responsive Surface Technology
Eight Sleep
Sleep Number
Vanda Pharmaceuticals
Eli Lilly
Neurim Pharmaceuticals
Merck

Market segment by Type, the product can be split into
Insomnia
Excessive Sleep
Disturbed Sleep

Market segment by Application, split into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Sleep Disorder Therapies status, future forecast, growth opportunity, key market and key players.
To present the Sleep Disorder Therapies development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Sleep Disorder Therapies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Sleep Disorder Therapies Market Size Growth Rate by Type (2014-2025)
1.4.2 Insomnia
1.4.3 Excessive Sleep
1.4.4 Disturbed Sleep
1.5 Market by Application
1.5.1 Global Sleep Disorder Therapies Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Sleep Disorder Therapies Market Size
2.2 Sleep Disorder Therapies Growth Trends by Regions
2.2.1 Sleep Disorder Therapies Market Size by Regions (2014-2025)
2.2.2 Sleep Disorder Therapies Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Sleep Disorder Therapies Market Size by Manufacturers
3.1.1 Global Sleep Disorder Therapies Revenue by Manufacturers (2014-2019)
3.1.2 Global Sleep Disorder Therapies Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Sleep Disorder Therapies Market Concentration Ratio (CR5 and HHI)
3.2 Sleep Disorder Therapies Key Players Head office and Area Served
3.3 Key Players Sleep Disorder Therapies Product/Solution/Service
3.4 Date of Enter into Sleep Disorder Therapies Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Sleep Disorder Therapies Market Size by Type (2014-2019)
4.2 Global Sleep Disorder Therapies Market Size by Application (2014-2019)

5 United States
5.1 United States Sleep Disorder Therapies Market Size (2014-2019)
5.2 Sleep Disorder Therapies Key Players in United States
5.3 United States Sleep Disorder Therapies Market Size by Type
5.4 United States Sleep Disorder Therapies Market Size by Application

6 Europe
6.1 Europe Sleep Disorder Therapies Market Size (2014-2019)
6.2 Sleep Disorder Therapies Key Players in Europe
6.3 Europe Sleep Disorder Therapies Market Size by Type
6.4 Europe Sleep Disorder Therapies Market Size by Application

7 China
7.1 China Sleep Disorder Therapies Market Size (2014-2019)
7.2 Sleep Disorder Therapies Key Players in China
7.3 China Sleep Disorder Therapies Market Size by Type
7.4 China Sleep Disorder Therapies Market Size by Application

8 Japan
8.1 Japan Sleep Disorder Therapies Market Size (2014-2019)
8.2 Sleep Disorder Therapies Key Players in Japan
8.3 Japan Sleep Disorder Therapies Market Size by Type
8.4 Japan Sleep Disorder Therapies Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Sleep Disorder Therapies Market Size (2014-2019)
9.2 Sleep Disorder Therapies Key Players in Southeast Asia
9.3 Southeast Asia Sleep Disorder Therapies Market Size by Type
9.4 Southeast Asia Sleep Disorder Therapies Market Size by Application

10 India
10.1 India Sleep Disorder Therapies Market Size (2014-2019)
10.2 Sleep Disorder Therapies Key Players in India
10.3 India Sleep Disorder Therapies Market Size by Type
10.4 India Sleep Disorder Therapies Market Size by Application

11 Central & South America
11.1 Central & South America Sleep Disorder Therapies Market Size (2014-2019)
11.2 Sleep Disorder Therapies Key Players in Central & South America
11.3 Central & South America Sleep Disorder Therapies Market Size by Type
11.4 Central & South America Sleep Disorder Therapies Market Size by Application

12 International Players Profiles
12.1 Sanofi
12.1.1 Sanofi Company Details
12.1.2 Company Description and Business Overview
12.1.3 Sleep Disorder Therapies Introduction
12.1.4 Sanofi Revenue in Sleep Disorder Therapies Business (2014-2019)
12.1.5 Sanofi Recent Development
12.2 Phillips Healthcare
12.2.1 Phillips Healthcare Company Details
12.2.2 Company Description and Business Overview
12.2.3 Sleep Disorder Therapies Introduction
12.2.4 Phillips Healthcare Revenue in Sleep Disorder Therapies Business (2014-2019)
12.2.5 Phillips Healthcare Recent Development
12.3 Nox Medical
12.3.1 Nox Medical Company Details
12.3.2 Company Description and Business Overview
12.3.3 Sleep Disorder Therapies Introduction
12.3.4 Nox Medical Revenue in Sleep Disorder Therapies Business (2014-2019)
12.3.5 Nox Medical Recent Development
12.4 Fisher and Paykel Healthcare
12.4.1 Fisher and Paykel Healthcare Company Details
12.4.2 Company Description and Business Overview
12.4.3 Sleep Disorder Therapies Introduction
12.4.4 Fisher and Paykel Healthcare Revenue in Sleep Disorder Therapies Business (2014-2019)
12.4.5 Fisher and Paykel Healthcare Recent Development
12.5 Responsive Surface Technology
12.5.1 Responsive Surface Technology Company Details
12.5.2 Company Description and Business Overview
12.5.3 Sleep Disorder Therapies Introduction
12.5.4 Responsive Surface Technology Revenue in Sleep Disorder Therapies Business (2014-2019)
12.5.5 Responsive Surface Technology Recent Development
12.6 Eight Sleep
12.6.1 Eight Sleep Company Details
12.6.2 Company Description and Business Overview
12.6.3 Sleep Disorder Therapies Introduction
12.6.4 Eight Sleep Revenue in Sleep Disorder Therapies Business (2014-2019)
12.6.5 Eight Sleep Recent Development
12.7 Sleep Number
12.7.1 Sleep Number Company Details
12.7.2 Company Description and Business Overview
12.7.3 Sleep Disorder Therapies Introduction
12.7.4 Sleep Number Revenue in Sleep Disorder Therapies Business (2014-2019)
12.7.5 Sleep Number Recent Development
12.8 Vanda Pharmaceuticals
12.8.1 Vanda Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Sleep Disorder Therapies Introduction
12.8.4 Vanda Pharmaceuticals Revenue in Sleep Disorder Therapies Business (2014-2019)
12.8.5 Vanda Pharmaceuticals Recent Development
12.9 Eli Lilly
12.9.1 Eli Lilly Company Details
12.9.2 Company Description and Business Overview
12.9.3 Sleep Disorder Therapies Introduction
12.9.4 Eli Lilly Revenue in Sleep Disorder Therapies Business (2014-2019)
12.9.5 Eli Lilly Recent Development
12.10 Neurim Pharmaceuticals
12.10.1 Neurim Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Sleep Disorder Therapies Introduction
12.10.4 Neurim Pharmaceuticals Revenue in Sleep Disorder Therapies Business (2014-2019)
12.10.5 Neurim Pharmaceuticals Recent Development
12.11 Merck

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details